The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Mechanisms of Bone Metastasis
Abstract
Extract: Cancer frequently spreads to bone, a process termed bone metastasis. Up to 70% of patients with breast cancer or prostate cancer, and 15 to 30% of patients with lung, colon, bladder or kidney cancer develop bone metastasis. Once tumors go to bone, such as in patients with breast cancer or prostate cancer, they are incurable, and only 20% of patients with breast cancer are still alive five years after they are found to have bone metastasis. It is estimated that about 350,000 people die with bone metastasis each year in the United States. Bone metastasis causes severe bone pain and can result in fractures without any injury, as well as other life-threatening conditions. There are two major types of bone metastasis, one in which bone destruction is the predominant feature and the other one in which new bone formation is predominant. Bone metastasis where bone destruction is the predominant feature is known as osteolytic, and that in which new bone formation is the primary feature is called osteoblastic. This classification for metastasis is really two extremes of a continuum because many patients can have both osteolytic and osteoblastic or mixtures of both in their bone metastasis. In fact, patients with prostate cancer who usually have bone metastasis that shows increased new bone formation also have increased bone destruction in the same lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y.-H., Inada, M., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80258-5 · Cited by 4,244
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator
Takeichi, M. (1991) · Science · doi:10.1126/science.2006419 · Cited by 3,284
Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W. H., Beddington, R. S. P., Mundlos, S., Olsen, B. R., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80259-7 · Cited by 2,814
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Integrins and other cell adhesion molecules
Albelda, S. M., & Buck, C. A. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199285 · Cited by 1,966
THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES
Batson, O. V. (1940) · Annals of Surgery · doi:10.1097/00000658-194007000-00016 · Cited by 1,922
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
Coleman, R. E. (2001) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0210 · Cited by 1,920
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Metastatic potential correlates with enzymatic degradation of basement membrane collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C. M., & Shafie, S. (1980) · Nature · doi:10.1038/284067a0 · Cited by 1,768
Parker, S. L., Tong, T., Bolden, S., & Wingo, P. A. (1996) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.46.1.5 · Cited by 1,759
Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W., & Van Roy, F. (1991) · Cell · doi:10.1016/0092-8674(91)90143-m · Cited by 1,656
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Evidence for a Novel Gene Associated With Low Tumor Metastatic Potential
Steeg, P. S., Bevilacqua, G., Kopper, L., Thorgeirsson, U. P., Talmadge, J. E., Liotta, L. A., & Sobel, M. E. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.3.200 · Cited by 1,300
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
STEIN, G. S., & LIAN, J. B. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-4-424 · Cited by 1,078
Hortobagyi, G. N., Theriault, R. L., Porter, L., Blayney, D., Lipton, A., Sinoff, C., Wheeler, H., Simeone, J. F., Seaman, J., Knight, R. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352401 · Cited by 1,026
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Behrens, J., Mareel, M. M., Van Roy, F. M., & Birchmeier, W. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.6.2435 · Cited by 946
Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Osteoclastic Bone Resorption by a Polarized Vacuolar Proton Pump
Blair, H. C., Teitelbaum, S. L., Ghiselli, R., & Gluck, S. (1989) · Science · doi:10.1126/science.2528207 · Cited by 860
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Tumor heterogeneity and the biology of cancer invasion and metastasis.
Fidler, I. J. (1978) · PubMed · Cited by 818
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
Mizuno, A., Amizuka, N., Irie, K., Murakami, A., Fujise, N., Kanno, T., Sato, Y., Nakagawa, N., Yasuda, H., Mochizuki, S.-I., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8697 · Cited by 775
Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., & Takeichi, M. (1993) · PubMed · Cited by 661
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Cell biology of the osteoclast
Roodman, G. D. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00061-2 · Cited by 571
Self-citationMin, H., Morony, S., Sarosi, I., Dunstan, C. R., Capparelli, C., Scully, S., Van, G., Kaufman, S., Kostenuik, P. J., Lacey, D. L., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.463 · Cited by 550
Tumor cell autocrine motility factor.
Liotta, L. A., Mandler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., & Schiffmann, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3302 · Cited by 533
Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201394498 · Cited by 518
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Self-citationPfeilschifter, J., Chenu, C., Bird, A., Mundy, G. R., & Roodman, D. G. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040116 · Cited by 468
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 445
Pfeilschifter, J., & Mundy, G. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2024 · Cited by 431
Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice.
Sasaki, A., Boyce, B. F., Story, B. M., Wright, K. R., Chapman, M., Boyce, R. W., Mundy, G. R., & Yoneda, T. (1995) · PubMed · Cited by 417
Role of the alpha v beta 3 integrin in human melanoma cell invasion.
Seftor, R. E., Seftor, E. A., Gehlsen, K. R., Stetler-Stevenson, W. G., Brown, P. D., Ruoslahti, E., & Hendrix, M. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1557 · Cited by 416
Overview of Bone Morphogenetic Proteins
Wozney, J. M. (2002) · Spine · doi:10.1097/00007632-200208151-00002 · Cited by 412
Choi, S. J., Cruz, J. C., Craig, F., Chung, H., Devlin, R. D., Roodman, G. D., & Alsina, M. (2000) · Blood · doi:10.1182/blood.v96.2.671 · Cited by 408
Self-citationAubin, J. E. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<73::aid-jcb11>3.0.co;2-l · Cited by 390
Randomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
Powles, T., Paterson, S., Kanis, J. A., McCloskey, E., Ashley, S., Tidy, A., Rosenqvist, K., Smith, I., Ottestad, L., Legault, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.080 · Cited by 377
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
Croucher, P. I. (2001) · Blood · doi:10.1182/blood.v98.13.3534 · Cited by 377
Effects of basic fibroblast growth factor on bone formation in vitro.
Canalis, E., Centrella, M., & McCarthy, T. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113490 · Cited by 368
A murine model of experimental metastasis to bone and bone marrow.
Arguello, F., Baggs, R. B., & Frantz, C. N. (1988) · PubMed · Cited by 357
The Cellular Basis of Site-Specific Tumor Metastasis
Flier, J. S., Underhill, L. H., & Zetter, B. R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003013220907 · Cited by 349
Han, J.-H., Choi, S. J., Kurihara, N., Koide, M., Oba, Y., & Roodman, G. D. (2001) · Blood · doi:10.1182/blood.v97.11.3349 · Cited by 328
Self-citationHarris, S. E., Bonewald, L. F., Harris, M. A., Sabatini, M., Dallas, S., Feng, J. Q., Ghosh-Choudhury, N., Wozney, J., & Mundy, G. R. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650090611 · Cited by 325
Reduction to Homozygosity of Genes on Chromosome 11 in Human Breast Neoplasia
Ali, I. U., Lidereau, R., Theillet, C., & Callahan, R. (1987) · Science · doi:10.1126/science.3659909 · Cited by 324
Biology of Osteoclast Activation in Cancer
Roodman, G. D. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.15.3562 · Cited by 306
Self-citationKodama, H., Nose, M., Niida, S., & Yamasaki, A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1291 · Cited by 281
Dallas, S. L., Miyazono, K., Skerry, T. M., Mundy, G. R., & Bonewald, L. F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.2.539 · Cited by 267
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Self-citationTsukii, K., Shima, N., Mochizuki, S.-I., Yamaguchi, K., Kinosaki, M., Yano, K., Shibata, O., Udagawa, N., Yasuda, H., Suda, T., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8610 · Cited by 238
Direct resorption of bone by human breast cancer cells in vitro
EILON, G., & MUNDY, G. R. (1978) · Nature · doi:10.1038/276726a0 · Cited by 235
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., & Goltzman, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49691-9 · Cited by 234
Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases
Chirgwin, J. M., & Guise, T. A. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i2.50 · Cited by 233
Choi, S. J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J., & Roodman, G. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13116 · Cited by 231
Self-citationRole of endothelin-1 in osteoblastic bone metastases
Guise, T. A., Yin, J. J., & Mohammad, K. S. (2003) · Cancer · doi:10.1002/cncr.11129 · Cited by 228
Mbalaviele, G., Dunstan, C. R., Sasaki, A., Williams, P. J., Mundy, G. R., & Yoneda, T. (1996) · PubMed · Cited by 227
Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., Goldfarb, R. H., Khoury, G., & Liotta, L. A. (1987) · PubMed · Cited by 227
In Vivo Stimulation of Endosteal Bone Formation by Basic Fibroblast Growth Factor in Rats
Mayahara, H., Ito, T., Nagai, H., Miyajima, H., Tsukuda, R., Taketomi, S., Mizoguchi, J., & Kato, K. (1993) · Growth Factors · doi:10.3109/08977199308991583 · Cited by 220
Oyajobi, B. O., Franchin, G., Williams, P. J., Pulkrabek, D., Gupta, A., Munoz, S., Grubbs, B., Zhao, M., Chen, D., Sherry, B., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3905 · Cited by 215
Charhon, S. A., Chapuy, M. C., Delvin, E. E., Valentin-Opran, A., Edouard, C. M., & Meunier, P. J. (1983) · Cancer · doi:10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j · Cited by 208
Taube, T., Beneton, M. N. C., McCloskey, E. V., Rogers, S., Greaves, M., & Kanis, J. A. (1992) · European Journal of Haematology · doi:10.1111/j.1600-0609.1992.tb00046.x · Cited by 194
Costa, L., Demers, L. M., Oliveira, A. G., Schaller, J. A., Costa, E. B., de Moura, M. C., & Lipton, A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.850 · Cited by 193
Cramer, S. D., Chen, Z., & Peehl, D. M. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65919-6 · Cited by 192
Sommers, C. L., Thompson, E. W., Torri, J. A., Kemler, R., Gelmann, E. P., & Byers, S. W. (1991) · PubMed · Cited by 180
Mareel, M. M., Behrens, J., Birchmeier, W., De Bruyne, G. K., Vleminckx, K., Hoogewijs, A., Fiers, W. C., & Van Roy, F. M. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470623 · Cited by 179
Rabbani, S. A., Desjardins, J., Bell, A. W., Banville, D., Mazar, A., Henkin, J., & Goltzman, D. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80893-9 · Cited by 174
Nip, J., Shibata, H., Loskutoff, D. J., Cheresh, D. A., & Brodt, P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116007 · Cited by 172
Chemotactic activity of theγ-carboxyglutamic acid containing protein in bone
Mundy, G. R., & Poser, J. W. (1983) · Calcified Tissue International · doi:10.1007/bf02405025 · Cited by 172
Wani, M. R. (1999) · Endocrinology · doi:10.1210/en.140.4.1927 · Cited by 172
Yi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Dallas, S. L., Park-Snyder, S., Miyazono, K., Twardzik, D., Mundy, G. R., & Bonewald, L. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37449-5 · Cited by 171
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer
Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C., & Kanis, J. A. (1994) · Bone · doi:10.1016/8756-3282(94)90703-x · Cited by 171
Transcription factors in bone: developmental and pathological aspects
Yang, X., & Karsenty, G. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02340-7 · Cited by 166
Scanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Unstable Expression of E‐Cadherin Adhesion Molecules in Metastatic Ovarian Tumor Cells
Hashimoto, M., Niwa, O., Nitta, Y., Takeichi, M., & Yokoro, K. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02336.x · Cited by 159
Barillé‐Nion, S., Collette, M., Bataille, R., & Amiot, M. (1995) · Blood · doi:10.1182/blood.v86.8.3151.3151 · Cited by 151
Teoh, G., & Anderson, K. C. (1997) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70413-5 · Cited by 146
Chemotactic responses of tumor cells to products of resorbing bone.
Orr, W., Varani, J., Gondek, M. D., Ward, P. A., & Mundy, G. R. (1979) · Science · doi:10.1126/science.569363 · Cited by 145
Cancer Invasion and Metastases
Liotta, L. A. (1990) · JAMA · doi:10.1001/jama.1990.03440080101032 · Cited by 142
The cellular heterogeneity of malignant neoplasms: implications for adjuvant chemotherapy.
Fidler, I. J., & Poste, G. H. (1985) · PubMed · Cited by 139
Magrangeas, F., Nasser, V., Avet‐Loiseau, H., Loriod, B., Decaux, O., Granjeaud, S., Bertucci, F., Birnbaum, D., Nguyen, C., Harousseau, J., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3385 · Cited by 136
The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae
Takuwa, Y., Masaki, Τ., & Yamashita, K. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90491-5 · Cited by 129
van der Pluijm, G., Sijmons, B., Vloedgraven, H. J., Deckers, M. M. L., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1077 · Cited by 124
Collagen and Collagen-derived Fragments Are Chemotactic for Tumor Cells
Mundy, G. R., DeMartino, S. A., & Rowe, D. W. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110334 · Cited by 120
Mechanisms of Bone Lesions in Multiple Myeloma
Bataille, R., Chappard, D., & Klein, B. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30345-9 · Cited by 114
Roudier, M. P., Vesselle, H. J., True, L. D., Higano, C. S., Ott, S. M., King, S. H., & Vessella, R. L. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022627421000 · Cited by 111
Immunocytochemistry reveals RANKL expression of myeloma cells
Sezer, O., Heider, U., Jakob, C., Zavrski, I., Eucker, J., Possinger, K., Sers, C., & Krenn, V. (2002) · Blood · doi:10.1182/blood-2002-01-0148 · Cited by 110
Nakai, M., Mundy, G. R., Williams, P. J., Boyce, B. F., & Yoneda, T. (1992) · PubMed · Cited by 109
Human bone marrow myeloma cells express RANKL.
Sezer, O., Heider, U., Jakob, C., Eucker, J., Possinger, K., & Roodman, G. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.1.353 · Cited by 104
Self-citationPavalko, F. M., Gerard-O’Riley, R. L., Ponik, S. M., Gallagher, P. J., Jin, Y., & Norvell, S. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10221 · Cited by 98
Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Percival, R. C., Yates, A. J. P., Gray, R. E., Galloway, J., Rogers, K., Neal, F. E., & Kanis, J. A. (1985) · BMJ · doi:10.1136/bmj.291.6498.776 · Cited by 96
Reddy, A. L., & Fialkow, P. (1979) · The Journal of Experimental Medicine · doi:10.1084/jem.150.4.878 · Cited by 95
Harinck, H. I. J., Bijvoet, O. L. M., Plantingh, A. T., Body, J., Elte, J. W. F., Sleeboom, H. P., Wildiers, J., & Neijt, J. P. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90215-4 · Cited by 93
Endothelin-1 Is a Potent Regulator of Human Bone Cell Metabolism In Vitro
Kasperk, C. H., Börcsök, I., Schairer, H. U., Schneider, U., Nawroth, P. P., Niethard, F. U., & Ziegler, R. (1997) · Calcified Tissue International · doi:10.1007/s002239900245 · Cited by 91
Sati, H. I. A., Greaves, M., Apperley, J. F., Russell, R. G. G., & Croucher, P. I. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01193.x · Cited by 91
Correlation Between Bone Metabolic Markers and Bone Scan in Prostatic Cancer
Maeda, H. A., Koizumi, M., Yoshimura, K., Yamauchi, T., Kawai, T., & Ogata, E. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65196-6 · Cited by 90
Lee, Y.-P., Schwarz, E. M., Davies, M., Jo, M., Gates, J. J., Zhang, X., Wu, J., & Lieberman, J. R. (2002) · PubMed · Cited by 88
Bone destruction and hypercalcemia in plasma cell myeloma.
Mundy, G. R., & Bertolini, D. R. (1986) · PubMed · Cited by 88
Uneda, S., Hata, H., Matsuno, F., Harada, N., Mitsuya, Y., Kawano, F., & Mitsuya, H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04040.x · Cited by 86
Horton, M. A., Dorey, E. L., Nesbitt, S. A., Samanen, J. M., Ali, F. E.-F., Stadel, J. M., Nichols, A. J., GREIG, R. G., & Helfrich, M. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080215 · Cited by 85
THE ROLE OF INTERLEUKIN-1β IN THE PATHOGENESIS OF MULTIPLE MYELOMA
Lust, J. A., & Donovan, K. A. (1999) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70115-5 · Cited by 85
Takuwa, Y., OHUE, Y., Takuwa, N., & Yamashita, K. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.6.e797 · Cited by 84
Tumor subpopulation interactions in metastasis.
Fr, M. (1983) · PubMed · Cited by 84
Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis
Hofbauer, L. C., & Heufelder, A. E. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390152 · Cited by 79
PTH and PTHrP Effects on the Skeleton
Karaplis, A. C., & Goltzman, D. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1026526703898 · Cited by 77
Cheung, W.-C., & Ness, B. V. (2002) · Leukemia · doi:10.1038/sj.leu.2402481 · Cited by 76
The Role of Vertebral Veins in the Dissemination of Prostatic Carcinoma
Dodds, P. R., Caride, V. J., & Lytton, B. (1981) · The Journal of Urology · doi:10.1016/s0022-5347(17)54735-7 · Cited by 75
Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo
Bataille, R., Chappard, D., & Baslé, M. F. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05609.x · Cited by 64
Growth Regulatory Factors and Bone
Mundy, G. R., Chen, D., Zhao, M., Dallas, S. L., Xu, C., & Harris, S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010015309973 · Cited by 57
Grano, M., Mori, G., Minielli, V., Cantatore, F. P., Colucci, S., & Zallone, A. Z. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2569 · Cited by 54
Oyajobi, B. O., & Mundy, G. R. (2003) · Cancer · doi:10.1002/cncr.11133 · Cited by 53
The potential role of bisphosphonates in prostate cancer
Oades, G. M., Coxon, J. P., & Colston, K. W. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500607 · Cited by 52
Partial characterization of a bone-derived chemotactic factor for tumor cells.
Orr, F. W., Varani, J., Gondek, M. D., Ward, P. A., & Mundy, G. R. (1980) · PubMed · Cited by 50
Ballester, O., Moscinski, L. C., Lyman, G. H., Chaney, J., Saba, H., Spiers, A. S. D., & Klein, C. (1994) · Blood · doi:10.1182/blood.v83.7.1903.1903 · Cited by 49
Microangiopathic Haemolytic Anaemia and Experimental Tumour‐Cell Emboli
Hilgard, P., & Gordon‐Smith, E. C. (1974) · British Journal of Haematology · doi:10.1111/j.1365-2141.1974.tb00508.x · Cited by 47
Pathophysiology of Skeletal Complications of Cancer
Mundy, G. R., & Martin, T. J. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77991-6_18 · Cited by 31
Cited by
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
Parker, C., Nilsson, S., Heinrich, D., Helle, S. I., O'Sullivan, J. M., Fosså, S. D., Chodacki, A., Wiechno, P., Logue, J., Seke, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213755 · Cited by 3,408
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Immune evasion in cancer: mechanistic basis and therapeutic strategies
Vinay, D. S., Ryan, E. P., Pawelec, G., Talib, W. H., Stagg, J., Elkord, E., Lichtor, T., Decker, W. K., Whelan, R. L., Kumara, H. M. C. S., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.004 · Cited by 1,625
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Metadata
- Authors
- Roodman, G. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-04-15
- Volume
- 350
- Issue
- 16
- Pages
- 1655-1664
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2102969047
- Cited by
- 2,755
- References
- 129
- FWCI
- 46.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.